Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Alkem Labs gets inspection report from USFDA for Gujarat API facility

      Alkem Labs gets inspection report from USFDA for Gujarat API facility

      supriya kashyap kashyap30 March 2017 11:22 AM IST
      New Delhi : Drug firm Alkem Laboratories said it has received establishment inspection report (EIR) from the US health regulator on the closure of its...
      ASSOCHAM Health and Wellness Summit - Awards 2017

      ASSOCHAM Health and Wellness Summit - Awards 2017

      supriya kashyap kashyap30 March 2017 11:22 AM IST
      Health Minister of Jharkhand, Ramchandra Chandravanshi has recently claimed that the state has come a long way from the day when Jharkhand was on 18th...
      Kerala Institute of Medical Sciences gets Rs 1300 crore investment from True North

      Kerala Institute of Medical Sciences gets Rs 1300 crore investment from True North

      supriya kashyap kashyap30 March 2017 11:18 AM IST
      Mumbai : In one of the largest healthcare transactions in India, the Kerala Institute of Medical Sciences (KIMS) will get USD 200 million from True...
      Lupin launches generic HIV drug in US market

      Lupin launches generic HIV drug in US market

      supriya kashyap kashyap30 March 2017 10:49 AM IST
      New Delhi : Drug firm Lupin has launched generic Abacavir and Lamivudine tablets used for treatment of human immunodeficiency infection in the...
      FDA approves Dupixent to treat Atopic Dermatitis

      FDA approves Dupixent to treat Atopic Dermatitis

      supriya kashyap kashyap30 March 2017 9:18 AM IST
      The U.S. Food and Drug Administration approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis)....
      NPPA identifies 634 suspected cases of overcharging

      NPPA identifies 634 suspected cases of overcharging

      supriya kashyap kashyap29 March 2017 11:59 AM IST
      New Delhi : National drug pricing regulator NPPA has identified 634 cases where non-compliance of notified ceiling prices is suspected, Parliament was...
      Aurobindo Pharma gets USFDA nod for Meropenem injection

      Aurobindo Pharma gets USFDA nod for Meropenem injection

      supriya kashyap kashyap29 March 2017 11:59 AM IST
      New Delhi : Drug firm Aurobindo Pharma has received final approval from the US health regulator for Meropenem injection used for treatment of...
      Suven Life gets patent for neuro-degenerative molecule

      Suven Life gets patent for neuro-degenerative molecule

      supriya kashyap kashyap29 March 2017 11:57 AM IST
      New Delhi : Drug firm Suven Life Sciences has received one product patent from New Zealand for its molecule to be used in the treatment of...
      Roche MS drug Ocrevus approved by FDA after three-month delay

      Roche MS drug Ocrevus approved by FDA after three-month delay

      supriya kashyap kashyap29 March 2017 11:57 AM IST
      The U.S. Food and Drug Administration (FDA) approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug...
      Dr Reddy

      Dr Reddy's to market Integra LifeSciences products in India

      supriya kashyap kashyap28 March 2017 11:17 AM IST
      Mumbai : Pharma firm Dr Reddy's Laboratories Limited and Nasdaq-listed Integra LifeSciences Holdings Corporation announced an exclusive distribution...
      EU regulator recommends suspending 300 drugs tested by Indian CRO firm

      EU regulator recommends suspending 300 drugs tested by Indian CRO firm

      supriya kashyap kashyap28 March 2017 11:17 AM IST
      New Delhi : The European drug regulator has recommended suspension of around 300 medicines on which bio equivalence studies were conducted by...
      Chinese drug approval boosts AstraZenecas lung cancer hopes

      Chinese drug approval boosts AstraZeneca's lung cancer hopes

      supriya kashyap kashyap28 March 2017 11:17 AM IST
      London : AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.Tagrisso is...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok